Syros Pharmaceuticals Inc... (SYRS)
NASDAQ: SYRS
· Real-Time Price · USD
0.03
0.00 (19.52%)
At close: Jun 09, 2025, 3:26 PM
Syros Pharmaceuticals Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -97.81M | -131.56M | -144.49M | -164.57M | -104.96M | -95.07M | -93.3M | -94.65M | -113.69M | -109.47M | -97.48M | -86.56M | -92.88M | -86.33M | -81.04M |
Depreciation & Amortization | 1.27M | 1.56M | 1.88M | 2.18M | 2.67M | 2.78M | 2.86M | 2.97M | 2.97M | 3.01M | 3.03M | 3.02M | 3.01M | 3.02M | 3.02M |
Stock-Based Compensation | 7.25M | 8.88M | 9.89M | 10.43M | 11.62M | 11.32M | 11.19M | 11.41M | 11.38M | 10.52M | 10.29M | 10.35M | 10.51M | 11.14M | 11.41M |
Other Working Capital | -5.07M | -4.76M | -821K | -1.74M | 505K | -4.14M | -6.55M | -8.28M | -6.67M | -7.82M | -11.99M | -8.98M | -12.22M | -10.07M | -8.19M |
Other Non-Cash Items | -12.87M | 7.43M | 5.79M | 20.59M | -39.47M | -44.23M | -44.27M | -37.27M | -6.51M | -1.72M | -1.65M | 706K | 612K | 511K | 1.86M |
Deferred Income Tax | 8.08M | 14.14M | 16.6M | 16.6M | 8.53M | 2.47M | n/a | n/a | -2.46M | -4.2M | -8.79M | -16.46M | -13.62M | -11.89M | -7.29M |
Change in Working Capital | 3.38M | -2.32M | 9.39M | 5.05M | -608K | -3.42M | -6.43M | -5.52M | -6.64M | -5.44M | -12.98M | -10.6M | -14.13M | -10.06M | -7.56M |
Operating Cash Flow | -100.02M | -111.19M | -103.91M | -109.71M | -122.23M | -126.16M | -129.95M | -123.06M | -114.95M | -107.29M | -107.57M | -99.54M | -106.5M | -93.62M | -79.6M |
Capital Expenditures | -38K | -38K | -37K | -272K | -908K | -1.24M | -1.35M | -1.24M | -812K | -794K | -1.11M | -1.25M | -1.03M | -1.24M | -1.8M |
Cash Acquisitions | 1.56M | 1.69M | -31.33M | -5.85M | -7.41M | -7.41M | 25.51M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -30.59M | -30.59M | -27.14M | -50.97M | -50.97M | -50.97M | -48.5M | n/a | -34.42M | -51.41M | -85.83M | -85.83M | -51.41M | -34.42M | n/a |
Sales Maturities Of Investments | 30.89M | 59.53M | 64.03M | 87.02M | 125.41M | 103.29M | 83.9M | 68.43M | 30.03M | 23.51M | 7.51M | n/a | -50M | -50M | -45M |
Other Investing Acitivies | 26.66M | 55.3M | 63.15M | 37.61M | 74.44M | 52.32M | 35.4M | 68.43M | 64.45M | 40.94M | -9.48M | -16.99M | -1.41M | 15.58M | 55M |
Investing Cash Flow | 1.95M | 30.59M | 38.45M | 37.34M | 73.54M | 51.09M | 34.05M | 67.19M | 29.22M | 5.73M | -45.01M | -52.65M | -52.44M | -35.66M | 3.2M |
Debt Repayment | n/a | n/a | -4K | -57K | -132K | -506K | -574K | -591K | -585K | -278K | -271K | -265K | 19.66M | 19.67M | 19.66M |
Common Stock Repurchased | 115K | n/a | n/a | n/a | 217K | 136K | 136K | 136K | 242K | 323K | 323K | 323K | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -114K | -119K | -16K | 249K | -2.27M | 12.17M | 11.87M | 11.85M | 14.42M | 27K | 315K | 459K | 864K | 1.13M | 1.28M |
Financial Cash Flow | 43.16M | 43.15M | 43.25M | 43.46M | -10.62M | 131.45M | 131.09M | 131.04M | 141.84M | -286K | 8K | 70.51M | 181.22M | 181.52M | 181.67M |
Net Cash Flow | -53.94M | -36.48M | -21.24M | -27.94M | -59.31M | 56.38M | 35.19M | 75.17M | 56.11M | -101.85M | -152.57M | -81.68M | 22.29M | 52.24M | 105.27M |
Free Cash Flow | -100.06M | -111.23M | -103.94M | -109.98M | -123.14M | -127.39M | -131.3M | -124.31M | -115.76M | -108.08M | -108.68M | -100.78M | -107.52M | -94.86M | -81.4M |